With a Bachelor’s in Molecular Biotechnology from the Autonomous University of Barcelona and a Master’s in Biopharmaceutical Sciences from Leiden University, Pere started his PhD in October 2018. His project is a collaboration between the MERLN Institute and the Department of Ophthalmology at the MUMC+, and is aimed at creating a stem cell-based regenerative therapy for treating corneal disease. Corneal disease is one of the leading causes of blindness and visual disability, affecting over 15 million people worldwide.
Today’s state of the art therapy involves selective replacement of the corneal endothelium with that of a donor. However, only one donor cornea is available for every seventy patients in need. In his PhD project, he will investigate the possibility of rapidly and reproducibly generating corneal cells from pluripotent stem cells that could be used for regenerative medicine.